BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Common Stock Warrants - ECPv6.0.9//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://commonstockwarrants.com
X-WR-CALDESC:Events for Common Stock Warrants
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20210314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20211107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211122T080000
DTEND;TZID=America/New_York:20211222T170000
DTSTAMP:20260421T042231
CREATED:20211123T025120Z
LAST-MODIFIED:20211124T142637Z
UID:692392-1637568000-1640192400@commonstockwarrants.com
SUMMARY:23andMe (NASDAQ: ME\, MEUSW) Announces Redemption of All Outstanding Warrants - BEGIN
DESCRIPTION:SUNNYVALE\, Calif.\, Nov. 22\, 2021 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”)\, a leading consumer genetics and research company\, today announced that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of Class A common stock of 23andMe that were issued under the Warrant Agreement\, dated October 1\, 2020 (the “Warrant Agreement”)\, by and between 23andMe and Continental Stock Transfer & Trust Company\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in the initial public offering (the “IPO”) of 23andMe\, which was formerly known as VG Acquisition Corp.\, and that remain outstanding at 5:00 p.m. New York City time on December 22\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, 23andMe will redeem all of its outstanding warrants to purchase Class A common stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, 23andMe is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last sales price (the “Reference Value”) of the Class A common stock equals or exceeds $10.00 per share on each of twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants. At the direction of 23andMe\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Class A common stock underlying such Warrants. Payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Class A common stock\, or (ii) on a “cashless basis\,” in which the exercising holder will receive a number of shares of Class A common stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Redemption Fair Market Value”) of the Class A common stock during the ten trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. 23andMe will provide holders of the Warrants with the Redemption Fair Market Value no later than one business day after such ten-trading-day period ends. In no event will the number of shares of Class A common stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Class A common stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Class A common stock\, the number of shares that the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of 23andMe\, its board of directors\, or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\n23andMe has filed a registration statement on Form S-1 (Registration No. 333-257768) (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) relating to the offer and sale of the shares of Class A common stock underlying the Warrants under the Securities Act of 1933\, as amended\, which Registration Statement previously has been declared effective by the SEC. \n\n\n\nThe SEC maintains an Internet website\, www.sec.gov\, through which copies of filings that 23andMe makes with the SEC\, including the prospectus filed as part of the Registration Statement\, are available. \n\n\n\nQuestions concerning redemption and exercise of the Warrants can be directed to the Warrant Agent at [1 State Street 30th Floor\, New York\, NY 10004-1561\, by telephone at (212) 509-4000 or by email at reorg@continentalstock.com.] \n\n\n\nNo Offer or SolicitationThis press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of 23andMe’s securities in any jurisdiction in which such offer\, solicitation\, or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. \n\n\n\nAbout 23andMeFounded in 2006 and headquartered in Sunnyvale\, California\, 23andMe is a leading consumer genetics and research company. 23andMe’s mission is to help people access\, understand\, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple U.S. Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world’s largest crowdsourced platform for genetic research\, with 80% of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases\, conditions\, and traits. The platform also powers the 23andMe therapeutics group\, which is currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas\, including oncology\, respiratory\, and cardiovascular diseases\, in addition to other therapeutic areas. More information is available at www.23andMe.com. \n\n\n\nForward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933\, as amended\, and Section 21E of the Securities Exchange Act of 1934\, as amended\, including\, without limitation\, statements regarding expectations regarding the redemption of the Warrants. All statements\, other than statements of historical fact\, included or incorporated in this press release\, are forward-looking statements. The words “anticipate\,” “believe\,” “continue\,” “could\,” “estimate\,” “expect\,” “intends\,” “may\,” “might\,” “plan\,” “possible\,” “potential\,” “predict\,” “project\,” “should\,” “would\,” and similar expressions may identify forward-looking statements\, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained herein are based on 23andMe’s current expectations and beliefs concerning future developments and their potential effects\, but there can be no assurance that these will be as anticipated. These forward-looking statements involve a number of risks\, uncertainties (some of which are beyond the control of 23andMe)\, or other assumptions that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks and uncertainties include\, but are not limited to\, risks related to the redemption of the Warrants\, as well as those factors described in the “Risk Factors” section and other sections of 23andMe’s most recent Quarterly Report on Form 10-Q and other current and periodic reports 23andMe files with the SEC from time to time. Investors are cautioned not to place undue reliance on any such forward-looking statements\, which speak only as of the date they are made. Except as required by law\, 23andMe does not undertake any obligation to update or revise any forward-looking statements whether as a result of new information\, future events\, or otherwise. \n\n\n\nContactsInvestor Relations Contact: investors@23andMe.comMedia Contact: press@23andMe.com
URL:https://commonstockwarrants.com/event/23andme-nasdaq-me-meusw-announces-redemption-of-all-outstanding-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/23ANDME_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20211122T080000
DTEND;TZID=America/Denver:20211222T170000
DTSTAMP:20260421T042231
CREATED:20211123T025237Z
LAST-MODIFIED:20211124T142626Z
UID:692390-1637568000-1640192400@commonstockwarrants.com
SUMMARY:Hillman Solutions Corp. (Nasdaq: HLMN\, HLMNW) Announces Redemption of All Outstanding Warrants - BEGIN
DESCRIPTION:CINCINNATI\, Nov. 22\, 2021 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (NASDAQ: HLMN)\, (“Hillman” or “the Company”)\, a leading hardware solutions company\, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock\, par value $0.0001 per share (the “Common Stock”)\, that were issued under the Amended and Restated Warrant Agreement (the “Warrant Agreement”)\, dated November 13\, 2020\, by and between the Company and Continental Stock Transfer & Trust Company (“CST”)\, as warrant agent (the “Warrant Agent”)\, as part of the units sold in the Company’s initial public offering (the “IPO”) and that remain outstanding at 5:00 p.m. New York City time on December 22\, 2021 (the “Redemption Date”) for a redemption price of $0.10 per Public Warrant. In addition\, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the “Private Warrants” and\, together with the Public Warrants\, the “Warrants”) on the same terms as the outstanding Public Warrants. \n\n\n\nUnder the terms of the Warrant Agreement\, the Company is entitled to redeem all of the outstanding Public Warrants at a redemption price of $0.10 per Public Warrant if (i) the last sales price (the “Reference Value”) of the Common Stock equals or exceeds $10.00 per share on any twenty trading days within any thirty-day trading period ending on the third trading day prior to the date on which a notice of redemption is given and (ii) if the Reference Value is less than $18.00 per share\, the Private Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants. At the direction of the Company\, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants. \n\n\n\nThe Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants. As the Reference Value is less than $18.00 per share\, payment upon exercise of the Warrants may be made either (i) in cash\, at an exercise price of $11.50 per share of Common Stock or (ii) on a “cashless basis” in which the exercising holder will receive a number of shares of Common Stock to be determined in accordance with the terms of the Warrant Agreement and based on the Redemption Date and the volume weighted average price (the “Fair Market Value”) of the Common Stock during the 10 trading days immediately following the date on which the notice of redemption is sent to holders of Warrants. The Company will provide holders the Fair Market Value no later than one business day after such 10-trading day period ends. In no event will the number of shares of Common Stock issued in connection with an exercise on a cashless basis exceed 0.361 shares of Common Stock per Warrant. If any holder of Warrants would\, after taking into account all of such holder’s Warrants exercised at one time\, be entitled to receive a fractional interest in a share of Common Stock\, the number of shares the holder will be entitled to receive will be rounded down to the nearest whole number of shares. \n\n\n\nAny Warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable\, and the holders of those Warrants will be entitled to receive only the redemption price of $0.10 per Warrant. \n\n\n\nNone of the Company\, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. \n\n\n\nThe shares of Common Stock underlying the Warrants have been registered by the Company under the Securities Act of 1933\, as amended\, and are covered by a registration statement filed on Form S-1 with\, and declared effective by\, the Securities and Exchange Commission (Registration No. 333-258823). The SEC maintains an Internet website that contains a copy of this prospectus. The address of that site is www.sec.gov. Alternatively\, you can obtain a copy of the prospectus from the Company’s investor relations website at https://ir.hillmangroup.com/financial-information. \n\n\n\nThis press release does not and will not constitute an offer to sell\, or the solicitation of an offer to buy\, the warrants\, any shares of Hillman’s common stock\, or any other securities\, nor will there be any sale of the warrants or any such shares or other securities\, in any state or other jurisdiction in which such offer\, sale or solicitation would be unlawful. \n\n\n\nAbout Hillman Solutions Corp. \n\n\n\nFounded in 1964 and headquartered in Cincinnati\, Ohio\, Hillman is a leading North American provider of complete hardware solutions\, delivered with industry best customer service to over 40\,000 locations. Hillman designs innovative product and merchandising solutions for complex categories that deliver an outstanding customer experience to home improvement centers\, mass merchants\, national and regional hardware stores\, pet supply stores\, and OEM & Industrial customers. Leveraging a world-class distribution and sales network\, Hillman delivers a “small business” experience with “big business” efficiency. For more information on Hillman\, visit www.hillmangroup.com. \n\n\n\nForward-Looking Statements \n\n\n\nThis press release may contain “forward-looking statements” within the meaning of the federal securities law. All statements other than statements of historical fact included in this presentation are forward-looking statements made in good faith by the company and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from their expectations\, estimates and projections and consequently\, you should not rely on these forward looking statements as predictions of future events. Words such as “expect\,” “estimate\,” “project\,” “budget\,” “forecast\,” “anticipate\,” “intend\,” “plan\,” “may\,” “will\,” “could\,” “should\,” “believes\,” “predicts\,” “potential\,” “continue\,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include\, without limitation\, the Company’s expectations with respect to future performance. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include\, but are not limited to: (1) unfavorable economic conditions that may affect operations\, financial condition and cash flows including inflation\, recessions\, instability in the financial markets or credit markets; (2) highly competitive markets that could adversely impact financial results (3) ability to continue to innovate with new products and services; (4) seasonality; (5) large customer concentration; (6) ability to recruit and retain qualified employees; (7) the outcome of any legal proceedings that may be instituted against the Company (8) adverse changes in currency exchange rates; (9) the impact of COVID-19 on the Company’s business; or (10) regulatory changes and potential legislation that could adversely impact financial results. The foregoing list of factors is not exclusive\, and readers should also refer to those risks that will be included under the header “Risk Factors” included in the S-1 filed on August 25\, 2021 with the Securities and Exchange Commission (“SEC”). Given these uncertainties\, current or prospective investors are cautioned not to place undue reliance on any such forward looking statements. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this presentation to reflect any change in its expectations or any change in events\, conditions or circumstances on which any such statement is based. All estimates of financial metrics in this presentation for fiscal 2021 and beyond are current as of the date of this press release. \n\n\n\nContact Information \n\n\n\nInvestors: \n\n\n\nVP Investor RelationsJennifer HillsJennifer.Hills@hillmangroup.com513-975-5248
URL:https://commonstockwarrants.com/event/hillman-solutions-corp-nasdaq-hlmn-hlmnw-announces-redemption-of-all-outstanding-warrants-begin/
CATEGORIES:Warrant Redemptions
ATTACH;FMTTYPE=image/png:https://commonstockwarrants.com/wp-content/uploads/2021/11/HILLMAN_logo.png
END:VEVENT
END:VCALENDAR